1
High IOP is a risk factor, not a diagnosis — most people with ocular hypertension never develop glaucoma
High Eye Pressure (IOP)
Elevated intraocular pressure puts you on the glaucoma-suspect watchlist. Most suspects never develop glaucoma, but IOP is the one risk factor you can influence.
Red Flags — Seek Care Immediately
- Severe eye pain + nausea/vomiting = possible angle-closure attack (ER now)
- Halos around lights + red eye + blurred vision = acute angle closure (ER now)
- Sudden vision loss in one eye (ER now)
- Rapidly worsening visual field or new blind spots (same-week exam)
What You Need to Know
The essential facts before we get into treatments.
2
IOP is the ONLY modifiable risk factor for glaucoma; proven treatments (drops, laser) are what actually protect the optic nerve
3
Caffeine raises IOP acutely, and habitual heavy caffeine raises IOP mainly in people with high genetic risk (UK Biobank, n=121,374)
4
Supplements are adjuncts at best — none is proven to replace or match prescription IOP treatment
Step one: cut the caffeine
Start here, before anyone hands you a prescription pad. IOP is the one glaucoma risk factor you can actually change, and caffeine is the lever with the strongest evidence behind it. Caffeine raises eye pressure within about an hour of a strong cup — a 2026 meta-analysis of 16 randomized trials found that doses over ~100 mg (about one strong coffee) raised IOP in both healthy and glaucomatous eyes, while lower doses didn't significantly move it. It won't fix everyone's number, and it doesn't replace your doctor's care. But it's free, it's yours to control, and for some of us it's the difference between watching your pressure and a lifetime of daily drops. Would you give up the second cup to keep your sight? A reasonable person would.
Source: doi:10.4103/joco.joco_43_26, J Curr Ophthalmol 2026, systematic review & meta-analysis.
What Actually Works (Evidence-Based)
These treatments have RCT data or major society guideline backing (AAO, TFOS, AREDS).
1
Monitoring / regular eye exams (visual field + OCT), the core of glaucoma-suspect care
2
Prostaglandin analogue eye drops (e.g. latanoprost), first-line, ~25–33% IOP reduction
3
Selective laser trabeculoplasty (SLT), a proven alternative to drops for many patients
4
Filtering surgery (trabeculectomy / drainage devices) for advanced or refractory cases
Low-Risk Adjunctive Options
These oral/topical interventions have early human data for symptomatic floater relief. They are investigational, not FDA-approved for floaters, and not replacements for observation or procedures.
1
Nicotinamide (vitamin B3)
Protocol: 3 g/day in trials, far above the ~16 mg RDA; not self-prescribed, discuss with your doctor first
Evidence: Phase 2 RCT (n=42): oral nicotinamide + pyruvate improved visual field vs placebo (De Moraes, JAMA Ophthalmol 2022). Crossover RCT (n=57): 3 g/day improved inner retinal function on ERG (Hui, Clin Exp Ophthalmol 2020). NOTE: neuroprotection — it does NOT lower IOP. AGS/AAO 2025 position: encouraging but not yet recommended; phase 3 trial (NAMinG) running.
[View study] doi:10.1001/jamaophthalmol.2021.4576
Closest match: Generic nicotinamide 500 mg capsules (3 g/day = 6 capsules — again, talk to your doctor)
2
Mirtogenol (French maritime pine bark + bilberry)
Protocol: 40 mg pine bark + 80 mg bilberry extract, 1–2 tablets/day
Evidence: Small studies show modest IOP reduction (~3 mmHg over 3 months) in ocular hypertension, and it may potentiate latanoprost (Steigerwalt, Mol Vis 2008; Clin Ophthalmol 2010). Small trials, mostly one research group.
[View study] doi:10.2147/opth.s9899
Closest match: Mirtogenol-branded supplement (pine bark + bilberry)
3
Saffron
Protocol: 30 mg/day saffron extract in trials
Evidence: Small RCT in POAG patients on drops: added modest IOP reduction (Jabbarpoor Bonyadi, BMC Complement Altern Med 2014). Single small trial.
[View study] doi:10.1186/1472-6882-14-399
Closest match: Saffron extract supplement (standardized to crocin)
4
Citicoline
Protocol: Oral 500–1000 mg/day, or 0.2% eye drops 3×/day in trials
Evidence: 2023 systematic review/meta-analysis: no significant effect on IOP, visual field, or retinal nerve fiber preservation. Some individual trials show hopeful signals on visual function, but the pooled evidence says no. Skeptical.
[View study] doi:10.1371/journal.pone.0291836
Closest match: Citicoline (CDP-choline) capsules
None of these supplements is FDA-approved for high IOP or glaucoma, and none replaces prescribed treatment or regular monitoring. Caffeine reduction is the lifestyle change with the strongest supporting data, especially if you're genetically susceptible. Supplements should be discussed with your ophthalmologist before starting.
Products with Data Behind Them
These match the adjunctive options and treatments above — we only list products with clinical evidence for their ingredients. Affiliate links support the site at no cost to you.
supplement
★★★★☆(746)
NOW Foods Niacinamide (Vitamin B-3) 500 mg
Nicotinamide (vitamin B3) is the adjunct with the strongest emerging neuroprotection data: a Phase 2 RCT (n=42, De Moraes, JAMA Ophthalmol 2022) improved visual field vs placebo, and a crossover RCT (n=57) improved inner retinal function on ERG (Hui, Clin Exp Ophthalmol 2020). It does NOT lower IOP — the goal is protecting the optic nerve. Trial dose is 3 g/day = 6 of these capsules, far above the RDA — discuss with your doctor first. [View study]
$7.95/ 100 servings
- Serving:
- 1 capsule
- Key:
- Niacinamide (B-3) 500 mg
Pros
- Cheap — the 3 g trial dose costs pennies a day
- Niacinamide form doesn't cause the niacin flush
- NOW is third-party tested
Cons
- Neuroprotection only — does NOT lower IOP
- Trial dose is 6 capsules/day, far above RDA
- Discuss with your ophthalmologist first
Affiliate link — we may earn a commission
supplement
★★★★☆(1,156)
Life Extension Eye Pressure Support with Mirtogenol
Mirtogenol is the patented pine bark + bilberry combination studied in ocular hypertension: modest IOP reduction (~3 mmHg over 3 months) and possible potentiation of latanoprost (Steigerwalt, Mol Vis 2008; Clin Ophthalmol 2010). Small trials, mostly one research group — treat as adjunctive, not a replacement for monitoring or drops. [View study]
$25.49/ 30 servings
- Serving:
- 1 capsule
- Key:
- Bilberry extract 80 mg, French maritime pine bark 40 mg
Pros
- Matches the studied Mirtogenol dosing
- Life Extension holds the Mirtogenol license
- May add to latanoprost effect
Cons
- Small trials, mostly one research group
- ~3 mmHg is modest — won't replace drops
- Talk to your doctor before starting
Affiliate link — we may earn a commission
supplement
★★★★☆(415)
Nootropics Depot High Potency Saffron Extract (30 mg)
The studied dose is 30 mg/day saffron extract, and this product is standardized to ≥7.5% crocins to match it. One small RCT in POAG patients on drops found added modest IOP reduction (Jabbarpoor Bonyadi, BMC Complement Altern Med 2014). Single trial. [View study]
$26.99/ 60 servings
- Serving:
- 1 capsule
- Key:
- Saffron extract 30 mg, Crocins ≥7.5%, Safranals ≥1%
Pros
- Exact 30 mg studied dose
- Standardized to ≥7.5% crocins
- Third-party tested
Cons
- Single small RCT
- Pricier than generic saffron
- Doesn't replace monitoring or drops
Affiliate link — we may earn a commission
supplement
★★★★☆(2,562)
Jarrow Formulas Citicoline (CDP-Choline) 250 mg
The 2023 systematic review/meta-analysis found no significant effect of citicoline on IOP, visual field, or retinal nerve fiber preservation; some individual trials show hopeful visual-function signals, but the pooled evidence says no. We're including this as some individual trials showed hopeful signals. [View study]
$44.94/ 120 servings
- Serving:
- 1 capsule
- Key:
- Citicoline (CDP-choline) 250 mg
Pros
- Established brand, good value per serving
- Trial range 500–1000 mg/day = 2–4 capsules
- Third-party tested
Cons
- Pooled meta-analysis: no significant effect
- Skeptical verdict, not a proven IOP treatment
- Discuss with your doctor
Affiliate link — we may earn a commission
What Doesn't Work (Save Your Money)
Glaucoma suspects get sold a lot of fear and a lot of bottles. None of these change the one thing that matters: your monitored IOP.
Eye exercises / Bates method (cannot change trabecular outflow or IOP)
Mega-dose vitamin C (weak historical data; kidney-stone risk at high doses)
Ginkgo for IOP (blood-flow studies in normal-tension glaucoma, not IOP lowering; bleeding risk)
Omega-3 for IOP (dry-eye evidence does not transfer to IOP)
Cannabis / THC (lowers IOP for only 3–4 hours; requires around-the-clock dosing that impairs function; drops blood pressure and may reduce optic nerve perfusion; no evidence it slows vision loss; AAO and GRF do not recommend it)
CBD (no human evidence it lowers IOP; 2008 study: 40 mg CBD raised IOP; may interfere with THC's effect; product variability and drug interactions)
When to See an Eye Doctor
If you're on a glaucoma-suspect watchlist, keep every scheduled exam — that IS the treatment. IOP fluctuates through the day, so a single normal reading doesn't clear you. New headache + eye pain + nausea? ER now — angle closure can cause irreversible vision loss in hours.
Helpful Guides
Author and Review Information
Medical information reviewed by NP Bate, Ed.S. • Last reviewed: 2026-08-08 • Not a substitute for professional care.